Cybin awarded notice of allowance from u.s. patent and trademark office for cyb004 (deuterated psychedelic tryptamine) for the treatment of anxiety disorders

Toronto--(business wire)--cybin awarded notice of allowance from u.s. patent and trademark office for cyb004

CYBN Ratings Summary

CYBN Quant Ranking